Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study

NCT05617846 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05617846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
December 28, 2024
Completion date
November 30, 2032
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication, limb; fusion